Minors come of age: Minor histocompatibility antigens and graft-versus-host disease

被引:25
作者
Chao, NJ [1 ]
机构
[1] Dept Med & Immunol, Durham, NC 27710 USA
基金
美国国家卫生研究院;
关键词
minor histocompatibility antigens; graft-versus-host disease;
D O I
10.1016/j.bbmt.2003.10.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Minor histocompatibility antigens (miHA) are responsible for the occurrence of graft-versus-host disease in the setting of a major histocompatibility complex matched sibling allogeneic stem cell transplantation. These miHA are peptide fragments that are associated with major histocompatibility complex class I or class H antigens. Elegant experiments have led to the molecular characterization of these antigens. Efforts to prevent graft-versus-host disease could be targeted through this pathway by matching for these miHA or by preventing antigen recognition. Alternatively, these miHA could be exploited as targets for a more potent graft-versus-malignancy effect. This area of miHA promises to continue to be an exciting area of continued research. (C) 2004 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:215 / 223
页数:9
相关论文
共 67 条
[1]   MAJOR HISTOCOMPATIBILITY COMPLEX - GENETICS AND BIOLOGY .2. [J].
BACH, FH ;
VANROOD, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (16) :872-878
[2]   Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor [J].
Balduini, CL ;
Frassoni, F ;
Noris, P ;
Klersy, C ;
Iannone, AM ;
Bacigalupo, A ;
Giorgiani, G ;
Di Pumpo, M ;
Locatelli, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (04) :951-953
[3]  
Behar E, 1996, NEW ENGL J MED, V334, P286, DOI 10.1056/NEJM199602013340502
[4]  
Billingham R E, 1966, Harvey Lect, V62, P21
[5]   Lack of GVHD across classical single minor histocompatibility (miH) locus barriers in mice [J].
Blazar, BR ;
Roopenian, DC ;
Taylor, PA ;
Christianson, GJ ;
PanoskaltsisMortari, A ;
Vallera, DA .
TRANSPLANTATION, 1996, 61 (04) :619-624
[6]  
BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.iy.12.040194.002005
[7]   The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing [J].
Brickner, AG ;
Warren, EH ;
Caldwell, JA ;
Akatsuka, Y ;
Golovina, TN ;
Zarling, AL ;
Shabanowitz, J ;
Eisenlohr, LC ;
Hunt, DF ;
Engelhard, VH ;
Riddell, SR .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :195-205
[8]   3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1 [J].
BROWN, JH ;
JARDETZKY, TS ;
GORGA, JC ;
STERN, LJ ;
URBAN, RG ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1993, 364 (6432) :33-39
[9]  
Chao N J, 1997, Biol Blood Marrow Transplant, V3, P1
[10]   CYCLOSPORINE, METHOTREXATE, AND PREDNISONE COMPARED WITH CYCLOSPORINE AND PREDNISONE FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE [J].
CHAO, NJ ;
SCHMIDT, GM ;
NILAND, JC ;
AMYLON, MD ;
DAGIS, AC ;
LONG, GD ;
NADEMANEE, AP ;
NEGRIN, RS ;
ODONNELL, MR ;
PARKER, PM ;
SMITH, EP ;
SNYDER, DS ;
STEIN, AS ;
WONG, RM ;
BLUME, KG ;
FORMAN, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (17) :1225-1230